Telcon RF Pharmaceutical Overview
- Founded
-
1999
- Status
-
Public
- Employees
-
131
- Stock Symbol
-
200230
- Investments
-
1
- Share Price
-
$0.75
- (As of Friday Closing)
Telcon RF Pharmaceutical General Information
Description
Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It is engaged in developing connectors for input and output port, board to board, cable assembly, and board to mount used in wireless communication equipment. The company also supply's RF coaxial connectors.
Contact Information
Primary Industry
Electrical Equipment
Other Industries
Connectivity Products
Fiberoptic Equipment
Stock Exchange
KRX
Primary Office
- 54, Gongse-ro
- Giheung-gu
- Yongin-si, Gyeonggi-do
- South Korea
+82 000-000-0000
Telcon RF Pharmaceutical Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.75 | $0.75 | $0.71 - $3.37 | $81.6M | 109M | 232K | -$0.56 |
Telcon RF Pharmaceutical Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 135,746 | 273,106 | 544,519 | 355,679 |
| Revenue | 26,394 | 33,037 | 28,069 | 45,004 |
| EBITDA | (46,371) | (9,620) | (29,189) | (41,787) |
| Net Income | (52,907) | (20,166) | (34,635) | (47,004) |
| Total Assets | 104,481 | 141,199 | 169,630 | 111,785 |
| Total Debt | 25,099 | 47,004 | 80,956 | 10,508 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Telcon RF Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Telcon RF Pharmaceutical Patents
Telcon RF Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018101542-A6 | Hybrid connector | Active | 16-Oct-2018 | 0000000000 | |
| AU-2018101542-A4 | Hybrid connector | Active | 16-Oct-2018 | 0000000000 | |
| AU-2017363816-A1 | Multiport cable terminal | Active | 28-Nov-2016 | 0000000000 | |
| AU-2017363816-B2 | Multiport cable terminal | Active | 28-Nov-2016 | 0000000000 | |
| AU-2017366073-B2 | Rotatable connector | Active | 28-Nov-2016 | H01R35/00 |
Telcon RF Pharmaceutical Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jin-hun Lim | Chief Executive Officer and President |
Telcon RF Pharmaceutical Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000-0000 00 | Telcon RF Pharmaceutical | Board Member | 000 0000 |
Telcon RF Pharmaceutical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Telcon RF Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Telcon RF Pharmaceutical Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 10-Aug-2016 | 000000000 | 000.00 | Drug Discovery |